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Staphylococcus aureus is commonly present in humans and animals.  It can cause a 
variety of suppurative infections, food intoxication and toxic shock syndrome. 
Antimicrobial resistant S. aureus, especially methicillin-resistant S. aureus (MRSA), 
have emerged and are a major public health concern. There is an increasing risk of 
food production animals serving as a reservoir and transmitting S. aureus and MRSA 
in community environments. Due to the increased food safety risk posed by MRSA in 
addition to its multidrug resistance, we were interested in determining the prevalence 
of S. aureus and MRSA in retail meat and investing the multidrug resistance of the S. 
aureus isolates.  A survey study was conducted, involving 480 retail ground meat 
samples (231 ground pork and 249 ground beef) collected in the Washington DC area 
from March 2009 to March 2010.  Approximately 42.08% (n = 202) of the samples 
were identified as S. aureus positive and one MRSA isolate was recovered from a 
ground beef sample. Antimicrobial resistance testing showed 53.34% of recovered S. 
  
aureus isolates exhibited different levels of antimicrobial resistance to CLI, CHL, 
GEN, LEVO, CIP, SYN and TGC. The MRSA isolate was resistant to 8 of 22 
antimicrobials tested. PFGE fingerprinting identified the MRSA isolate as USA300 
subtype, which also carried genes of virulence factors PVL and protein A. Our 
findings indicated that antimicrobial resistant S. aureus strains were common in retail 
ground beef and port, and that MRSA could also be present in such products that 
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Chapter 1: INTRODUCTION 
Microbiology of Staphylococcus aureus  
In 1880, Staphylococcus aureus was first discovered by a surgeon named Sir 
Clifton Smith in pus from surgical abscesses in Aberdeen, Scotland (1). It is a non-
motile, non-sporeforming, Gram positive, facultative anaerobic coccus, with the 
appearance of grape-like clusters when viewed through a microscope.  The S. aureus 
spherical cells are about 1 micrometer in diameter, and form a cluster shape because 
of the special division way of Staphylococci, the cells dividing in both three 
dimensional axis and the new cells remaining attached to each other followed by each 
division successively. Since there is no exact point of division, the result is to form an 
irregular cells cluster (2). S. aureus is catalase positive and oxidase negative. When 
without a microscope, the catalase test is an important but very simple method to 
distinguish Staphylococci from Streptococci, which is catalase negative (3). Typical 
S. aureus has a large, round, creamy smooth colonies with golden yellow color. Most 
strains have beta or alpha hemolysis when growing on blood agar plates (4).  S. 
aureus can survive for several hours on dry environmental surfaces (5), and grow at a 
temperature range of 7 to 48oC.  It can tolerate NaCl concentrations as high as 15 
percent (6). From the sequenced S. aureus strains, the range of genomes size is 
around 2.8 to 2.9 Mbp (7-9), which include 75% essential genes for cell surviving and 
other accessory genome, bacteriaphages and pathogenicity island that contains 





Table 1-1. Staphylococcus aureus genomics 
Genomic Characteristics  
Size of genomic DNA (Mbp) 2.8 - 2.9 
Predicted protein-coding sequences (genes) 2565 - 2671 
Percentage of core component genes (%) 75% 
 
There are more than 20 species of Staphylococcus described in Bergey’s 
Manual (2001) (11), but only S. aureus and Staphylococcus epidermidis have 
significant impact on human health. When growing on a nutrient media, brain heart 
infusion (BHI) agar for instance, S. aureus normally produces bigger, yellow, creamy 
colony, and hemolysis should be observed when grown on blood agar plates. S. 
epidermidis has a smaller white colony with no hemolysis. In addition, nearly all S. 
aureus are coagulase positive and most S. epidermidis are coagulase negative (12-13). 
Unlike S. aureus, which should always be considered as pathogen, the majority of S. 
epidermidis is nonphathogenic and belongs to a part of the normal flora that plays a 
role of protection. However, S. epidermidis may be considered as a pathogen in a 
clinical environment (14). 
 
Reservoir of S. aureus 
S. aureus can survive in various environments and has a wide range of natural 
reservoir (15). It may occur as a commensal flora on human skin and also in the nose 
and most other anatomical locales, including oral cavity and gastrointestinal tract. 
Approximately 20% of the human populations are long term S. aureus carriers and 
about 60% of the population can be colonized by S. aureus intermittently. Intravenous 




person and healthcare workers tend to have a higher rate of S. aureus carriage (15-
16). However, the presence of S. aureus under those circumstances does not always 
indicate an infection occurred. In addition, S. aureus can also be present in many 
domesticated animals such as cats, dogs or horses (18-20). Food production animals 
are another important reservoir for S. aureus.  Pigs and cows are generally colonized 
by S. aureus at farming condition. It causes septicemia in pigs and responsible for 
majority of mastitis cases in cattle (21-22).  
 
Virulence factors of S. aureus  
The majority of S. aureus strains can express more than one virulence factor. 
Various virulence or virulence-like genes on S. aureus chromosome code for surface 
virulent structures and secreted proteins as well as other regulators which help it 
adapt to the host environments. (Figure 1-1)  
 
 





Among various potential virulence factors, seven groups have been identified 
as the major causes of S. aureus infections: 
1. Adhesins 
Adhesins are surface proteins that promote the colonization of host tissues (23). 
S. aureus cells can express several surface proteins to help the bacteria attach to 
the host cells. Laminin and fibronectin are two major components that form an 
extracellular matrix on the epithelial or endothelial surfaces. In addition, the 
expression of fibrin or fibrinogen binding protein is very common in S. aureus. 
These are clumping factors that can help the bacterial cells to attach to blood 
clots and traumatized tissue. Most S. aureus strains can express both adherence 
factors (23-25). 
2. Invasins 
Invasins of S. aureus are a group of extracellular proteins that promote bacteria 
to spread into tissues, such as leukocidin, kinases, and hyaluronidase (26). 
Leukocidin is one of the primary virulence factors in S. aureus, and is a multi-
component protein, which has been produced separately and acts together as a 
membrane pore forming toxin. The target of this virulence factor is 
polymorphonuclear leukocytes (27).   
3. Surface factors  
S. aureus can produce various surface factors that help it inhibit the phagocytic 
engulfment. Amount these surface factors, protein A is the most important 




molecular at a wrong orientation, which leads to the disfunction of IgG protein 
and eventually disrupts phagocytosis and opsonization (23, 28).   
4. Superantigens (PTSAgs) 
S. aureus secretes two different toxins that have superantigen activity. The 
secreted superantigens stimulate the non-specific activity of T cell without a 
normal antigenic recognition. Cytokines are  released in a large amount and lead 
to disease symptoms (26). One is enterotoxin which has six subtypes: SE-A, 
SE-B, SE-C, SE-D, SE-E and SE-G. Enterotoxins can cause food poisoning by 
cause GI tract symptoms, such as diarrhea and vomiting, after they are ingested. 
Another superantigen that S. aureus commonly produced is toxic shock 
syndronme toxin (TSST-1), which is the cause of toxic shock syndrome (TSS) 
(29).  
5. Exfoliatin toxin (ET) 
Exfoliatin toxin has two distinct antigenic forms, ETA and ETB. They both 
have protease activity that causes separation within the epidermis, through the 
stratum granulosum layer of the epidermis, between the superficial dead layers 
and the living layers. ET is related with the staphylococcal scalded skin 
syndrome (SSSS), which commonly occurs in infant or young children (29).  
6. Other toxins 
S. aureus also express a variety of other membrane damaging toxins including 
alpha-toxin, beta-toxin, delta-toxin and several bicomponent toxins. Alpha-toxin 
is a pore forming toxin, which also called as alpha-hemolysin. Human platelets 




sphingomyelin and damages membranes with rich lipid (31-32). The rules of 
delta-toxin remain unknown. It is a very small peptide that can be expressed by 
most S. aureus strains and some S. epidermidis. 
7. Antimicrobial resistance elements 
S. aureus can also acquire antimicrobial resistance through plasmid and other 
mobile elements. More than one antimicrobial resistance gene can be located at 
S. aureus simultaneously and leads to multidrug resistance (33).  In addition, 
efflux pump systems also work as antimicrobial resistance elements in S. aureus 
(34-35). 
 
Antimicrobial Resistance of S. aureus and MRSA 
Before the first antimicrobial was discovered, the mortality of S. aureus 
bacteremia was over 80%, and more than 70% of patients developed metastatic 
infections (36). In early 1940s, the introduction of penicillin significantly increased 
the survival rate of S. aureus infections. However, only 2 years later, the first 
penicillin resistant S. aureus was isolated in a clinical environment, and since then 
resistance pattern has been spreading from hospital to community (15). Penicillin is 
inactivated by penicillinase (beta-lactmase) (36-37). 
New antimicrobials have been continuously introduced. However, widespread 
and inappropriate use of antimicrobials, along with lacking of efficient antimicrobial 
administration, large scale use of antimicrobial agents in animal feed as growth 
enhancers and increased international population movements, has contributed to the 




aureus (38-39). As rapidly as a new antimicrobial is introduced into commercial use, 
S. aureus develops efficient mechanisms to neutralize it.  
Methicillin, as the first beta-lactamase resistant penicillin, was used to treat S. 
aureus infection in 1961 (40).  The first methicillin-resistant S. aureus (MRSA) was 
identified in the United Kingdom in the same year. It appeared in the United States in 
1981 among intravenous drug users (43). Although there is no exact definition for 
MRSA currently, MRSA is commonly referred to as multidrug-resistant S. aureus or 
oxacillin-resistant S. aureus (ORSA). It is a special group of S. aureus that have 
acquired the ability to resist a large group of antimicrobials called the beta-lactams, 
including penicillin, methicillin, dicloxacillin, oxacillin and cefoxitin. In the United 
States, there is a significantly increase number of MRSA infections during the past 
decade. A 2007 report from Centers for Disease Control and Prevention (CDC) 
showed that the number of MRSA infections in clinical environment was doubled 
nationwide. The annual number of the infected cases increased from approximately 
127,000 cases in 1999 to 278,000 in 2005, and the annual death number also 
increased from 11,000 to more than 17,000 at the same time period (44). When 
comparing with patients without normal S. aureus infections, a 2004 study indicated 
that in the United States the patients who suffered from MRSA infections had 
approximately three times the length of hospitalization and three times the total cost. 
In addition, the risk of death increases by five times (45). Several other studies also 
show that MRSA contributed to a higher mortality of infection than methicillin-
susceptible S. aureus (MSSA) (46). Currently, MRSA is divided into two subgroups: 




(CA-MRSA). HA-MRSA is the major problem in nosocomial infections. For 
instance, patients in hospital with open wounds, invasive devices or under 
immunocompromise conditions are at much higher risk of getting MRSA infection. 
On the other hand, the CA-MRSA has recently risen as a major public health concern. 
Although the border between HA-MRSA and CA-MRSA are not clearly 
distinguishable, CA-MRSA infections are generally caused by the MRSA strains that 
differ from the HA-MRSA strains. Comparing with the better understood HA-MRSA, 
CA-MRSA has its own new characteristics that are still under study (47). Also, CA-
MRSA can be defined by characteristics of patients who develop MRSA infections 
including no contact of healthcare facilities and no history of longtime 
hospitalization. In the mid-1990s, the first CA-MRSA case was reported in Australia. 
Soon after that, CA-MRSA infections have been reported in many countries including 
France, Finland, New Zealand and the United Kingdom. In North American, the 
United States and Canada also have had reported cases (48-50). In United States, the 
new CA-MRSA strains have rapidly become the most common cause of skin 
infections among individuals out of hospital environment.  Unlike HA-MRSA, these 
strains tend to infect much younger populations. The average age of infection 
population is under 20 years old (51). To date, several reports have documented CA-
MRSA infections due to the contact of food animal or consumption of food products 
(52-57). Several studies have reported MRSA strains from various food products 
including meats, dairy products and even other processed food including salad 




At the molecular genetics level, when comparing with traditional S. aureus 
strains, MRSA strains contain additional motile chromosomal DNA fragment, which 
is called Staphylococcus Chromosome Cassette mec or SCCmec genomic island. The 
genetic element is approximately 30 to 50 kb (33, 58-59). On the SCCmec, it contains 
mecA gene encoding penicillin binding protein (PBP) 2a or 2’, and regulatory genes 
mecI and mecR1 that are located immediately at upstream of the mecA promoter (58-
59). Studies reported that the original mecA gene may come from a coagulase-
negative Staphylococcus species, most possibly S. sciuri, or a close evolutionary 
relative of  this species (60). The PBP-2a protein encoded by mecA is an inducible 76 
kDa PBP responsible for the methicillin resistance (60).  
In general, S. aureus produces four major PBPs, PBP 1 to 4, which catalyze 
the transpeptidation reaction that cross-links the peptidoglycan of the bacterial cell 
wall. It is essential for the cell wall synthesis, but beta lactam antimicrobials can bind 
to the original PBP active site and thereby inhibit the cell wall synthesis. However, 
PBP-2a, which has a reduced affinity for binding with beta lactam antimicrobials (61-
62), can substitute for the essential cell well synthesis function of original high-
affinity PBPs at the lethal concentration of antimicrobials therefore the bacteria 
survive.  
In additional to resistance to methicillin, MRSA strains commonly exhibit 
multidrug resistance. Because of the higher antimicrobial pressure in clinical 
environment, HA-MRSA tends to have a higher antimicrobial resistance spectrum 
than CA-MRSA. In addition to mecA gene, SCCmec cassette may contain other 




resistance genes on chromosome and/or plasmids. For instance, vanA gene, which is 
responsible for vancomycin resistance, is located on a 60 kb plasmid (63). On another 
aspect, efflux pumps also contribute to a certain level of antimicrobial resistance in S. 
aureus (34-35). 
 
S. aureus pathogenesis 
Each year about 500,000 patients in American hospitals contract a 
Staphylococcal infection (17).  Human staphylococcal infections are frequent. 
However, in most cases it usually remains localized at the portal of entry by the 
normal host defenses. The portal of infection usually is a break in the skin including a 
minute needle-like stick to a surgical wound, most commonly happens for burning 
wounds (20, 51). Another important portal of entry is the respiratory tract. Pneumonia 
caused by S. aureus is a frequent complication of influenza infection. The localized 
host response to Staphylococcal infection is inflammation which is characterized by 
an infection site temperature elevation. Swelling, pus accumulation and tissue 
necrosis may be caused by the immune response of leukocytes and a fibrin clot may 
form around the inflamed area to wall off the bacteria. In some cases, more serious 
infections of the skin may also occur, such as furuncles or impetigo. In addition to 
various superficial infections, severe deep site infections may occur if the bacteria get 
into organs or deep tissues. S. aureus can cause infections in the kidney which may 
lead to kidney failure, infect the heart causing endocarditis, and invade meninges 
leading to meningitis (26). Osteomyelitis can occur as the result of the localized bone 




bacteria invade the blood stream may be fatal and a bacteremia may result in seeding 
other internal abscesses.  
Additionally, various types of toxins produced by S. aureus can lead to 
different diseases. In infants, S. aureus infection can cause Staphylococcal Scalded 
Skin Syndrome (SSSS) by ET toxin (26). Some strains of S. aureus, which produce 
exotoxin TSST-1 into the blood stream, are the causative agent of Toxic Shock 
Syndrome (TSS) (64). Currently, TSS is highly related with tampon use in women, 
and TSST-1 is responsible for all menstrual cases and also 75% of total cases (65-66).  
S. aureus can also cause gastroenteritis by releasing enterotoxins into food 
products. Symptoms include nausea, vomiting, abdominal cramps and diarrhea (52, 
64).  In some severe cases, headache, muscular cramps or blood pressure change may 
also occur. The gastroenteritis is normally self-limited and the symptoms begin 
release generally in 8-24 hours. However, death may also happen for infants or old 
people. If the enterotoxin is released systematically in human body, it can also cause 
TSS. In fact, 50% of non-menstrual cases of TSS are caused by enterotoxins B and C.  
MRSA infection has its own unique features. Followed by the initial typical 
symptoms, MRSA infection progresses substantially within the next 24 to 48 hours. 
After 72 hours, MRSA can get into deeper human tissues and become resistant to 
treatment. The initial symptom of MRSA infection show a small red spider bites 
bumps that may be accompanied by fever and occasionally rashes (67-68). Within a 
few days the spider bites bumps become larger, more painful and eventually open into 
deep, pus-filled boils (68-69). MRSA can be very hard to eliminate because of its 




period for healthy individuals varies from a few weeks to many years 
asymptomatically (70). Patients with compromised immune systems are at a 
significantly higher risk of symptomatic secondary infection (45). Compare with HA-
MRSA, CA-MRSA display some characteristics, such as enhanced virulence, more 
rapidly spreading, which lead to a higher risk to get more severe diseases (71-73). 
For the majority of diseases caused by S. aureus, pathogenesis is multi 
factorial. It is difficult to precisely determine the role of any given virulence factor 
(74). However, evidences have been found that the expression of particular virulence 
determinants have correlations with strains isolated from particular diseases, which 
may suggests their specific role in particular diseases. In addition, the application of 
various molecular biology methods has led to advances in unraveling the 
pathogenesis of Staphylococcal diseases. Genes which encoding potential virulence 
factors have been sequenced and cloned, various toxin proteins have been identified 
and purified. With some staphylococcal toxins, symptoms of human disease can be 
reproduced in animal models with the purified protein toxins, lending to better 
understanding of mechanism of action (7, 75-77).  
 
Laboratory Diagnosis  
The diagnosis of S. aureus infection depends upon the symptoms of patient 
and the healthcare advisor’s evaluation. Obtaining an appropriate specimen is the first 
step of definitive diagnosis of S. aureus infection. Based on the type of infection 
presented, the specimen can be collected accordingly and sent to a laboratory for 




Under laboratory condition, a Gram stain can be performed as the first 
identification step. If Gram positive cocci are observed under microscope, further 
tests should be performed. Secondly, culturing the suspect specimen on selective 
medium, such as Mannitol Salt Agar (MSA), BP agar or other chromogenic agars to 
differentiate Staphylococci or S. aureus from other bacteria, can be used to obtain the 
typical single colony. Typical S. aureus should show a big creamy yellow colony 
surrounded by yellow area on MSA or Big glossy black colony surrounded by clear 
hole on BP agar. Under certain cases, selective medium that contain specific 
antimicrobials may used to identify the antimicrobial resistant ability of the isolates. 
For instance, BP agar with 4µg/ml oxacillin can be used to identify MRSA from 
specimen. MIC test is also needed to determine the antimicrobial susceptibility.  
To differentiate on the species level, several biochemical tests can be 
performed, such as catalase test and coagulase test. A typical S. aureus isolate show a 
strange catalase positive and coagulase positive results. For the confirmation of 
diagnosis or subtyping of the obtained isolates, molecular based methods are 
currently the most popular choose. Among all of molecular methods, PCR for nuc or 
fem gene is the most commonly used to confirm isolate identification as S. aureus.  
Pulsed-field gel electrophoresis (PFGE) can be used to sub-categorize MRSA 
isolates from USA100 to USA1200 (78). In addition, enzyme based assays such as 
ELISA against protein A are also a good choose for diagnosis. Multilocus sequence 
typing (MLST) is an effective methods that can be used to detect the different types 




For diagnosis, there is no exact “the one” method, especially for MRSA. 
Based on different situations, various combinations of currently valid diagnostic 
methods can be determined case by case. 
 
Treatment of S. aureus infections  
The first choice of treatment for S. aureus infection is penicillin. However, 
since penicillin-resistance is extremely common in many countries, the penicillinase-
resistant antimicrobials such as oxacillin or methicillin was developed as the first-line 
therapy to treat penicillin resistant S. aureus infections. Combination therapy with 
gentamicin may be used to treat severe infections like endocarditis (80), but its use is 
controversial because of its high risk of kidney damage (81).  
Both HA-MRSA and CA-MRSA are resistant to most anti-beta-lactamase 
antimicrobials. HA-MRSA has a greater spectrum of antimicrobial resistance; it is 
often susceptible only to vancomcin (82). CA-MRSA may be susceptible to sulfa 
drugs, tetracyclines and clindamycin, but the drug of choice for treating CA-MRSA 
has not been established (21). Newer drugs, such as linezolid may be effective against 
both HA-MRSA and CA-MRSA, but the susceptibility also keeps reducing recent 
years (83-84). Currently, the fisrt-line treatment for severe invasive MRSA infection 
is glycopeptides antimicrobials, such as vancomycin. However, this type of 
antimicrobial has no oral preparation available and its side-effects for human body are 
also the mainly concern (81). In addition, a particularly concern about using 




not penetrate into the infected tissues very well, and the susceptibility also reduced 
(85-86). 
Because of the existing high level of resistance in MRSA and the increasing 
resistance to vancomycin, CDC published a guideline for using vancomycin 
appropriately. And methicillin-sensitive S. aureus must not be treated by 
glycopeptides as outcomes are inferior (87-88). A new antibiotic, platensimycin, was 
recently identified and has shown promising potential against MRSA (46, 87). Phage 
therapy can be another potential treatment option (89), and showed its effectiveness 
against S. aureus infection in mice (90). In addition, it has been reported that maggot 
therapy to clean out necrotic tissue of MRSA infection has been successful (91).  
 
S. aureus and MRSA in food products  
Unlike other common foodborne pathogens such as E. coli or Salmonella, S. 
aureus does not cause illness by the bacteria itself.  Instead, the enterotoxin produced 
by S. aureus can lead to food poisoning under certain conditions when the food has 
been contaminated by S. aureus (56, 64). Since S. aureus is ubiquitous and very 
common to be found at domestic animals, food contamination with the pathogen is 
common (53, 92-93). Various food products are frequently contaminated by S. aureus 
and incriminated for S. aureus food poisoning including meat products, eggs, dairy 
products, vegetables and other processed food such as sandwich fillings or chocolate 
éclairs (92). Also, inappropriate food handling during preparation may bring S. 
aureus into food and temperature abuse after preparation is commonly involved with 




are also responsible for S. aureus contamination. Food poisoning could happen if the 
contaminated food has not been kept in the right temperature range, below 7.2°C or 
greater than 60°C (94-95). In addition, contact with the contaminated food products 
or food handler may also bring the risk of various S. aureus infections (96).  
Since S. aureus can colonize on various sites of food animals 
asymptomatically, such as pig or cow. These animals may serve as reservoir and/or a 
transmission vehicle of spreading S. aureus and MRSA. Food products derived from 
the animals may be contaminated with S. aureus or MRSA during slaughtering and 
processing (54). MRSA has been isolated from meat or dairy products in several 
countries including Netherlands, Italy, Australia, Japan and United States (53, 56, 92, 
93).  More studies are needed to determine the role of meat products as a potential 




1. To determine the prevalence of S. aureus and MRSA in retail meats. 
2. To study antimicrobial susceptibility of S. aureus and MRSA. 











Chapter 2: MATERIALS AND METHODS 
Sampling 
To assess the prevalence of S. aureus and MRSA in retail meats, 480 meat 
samples (231 ground pork and 249 ground beef) were collected weekly from three 
local grocery stores of three major chains in the Washington D.C. area from March 
2009 to March 2010. Each week 12 samples including 2 ground beef and 2 ground 
pork were randomly collected from each store.  
 
Isolation of S. aureus and MRSA from retail meats  
Each meat sample (50 g) was added to a plastic filter bag (Fisher, Pittsburg, 
PA) with 100 ml buffered peptone water (BPW, BD Diagnostic Systems, Sparks, 
MD) and followed by mixing at 230rpm for 1 minute in a stomacher (Seward, 
Bohemia, NY). Then 3 ml of the meat rinse were added to 27 ml of modified tryptic 
soy broth (mTSB, BD Diagnostic Systems, Sparks, MD) which contained 6.5% NaCl 
and 1% sodium pyrate (Fisher, Pittsburg, PA), and incubated at 35℃ for 48 hours 
with shaking at 150rpm. Bacterial genomic DNA was extracted directly from the 
enrichment broth and a PCR pre-screening was performed. Enrichment broth (1 ml) 
from each sample was added to a 1.5 ml centrifuge tube, followed by centrifugation at 
13,000 rpm for 30 s.  After removing supernatant, a second centrifugation at 13,000 
rpm for 30 s was applied.  The remaining supernatant was removed, and bacterial 




exposed by boiling the bacterial mixture at 100℃  heat block for 15 min. After 
heating, the tube was centrifuged at 12,000xg for 5 min.  The supernatant was used 
for DNA template in a multiplex PCR targeting S. aureus specific gene nuc and 
methicillin resistance gene mecA (Table 2-1). The PCR was performed at a 25 μl 
reaction solution containing 2 μl of DNA template, 2.5 μl of 10×PCR buffer, 2 μl of a 
1.25 mM mixture of deoxynucleoside triphophate, 4 μl of 25 mM MgCl2, and 0.25 μl 
of 5 U of AmpliTaq Gold DNA polymerase (Applied Biosystems, Branchburg, NJ) 
and 0.25 μl (12pmol) mecA and 0.25 μl (6pmol) nuc oligonucleotide primer 
(Invitrogen, Carlsbad, CA). Thermocycling protocol included an initial denaturation 
at 94 °C for 10 min, followed by 30 cycles of denaturation (94 °C for 15 s), annealing 
(55 °C for 30 s), and extension (72 °C for 30 s), and a final extension at 72 °C for 10 
min. PCR product (4 μl) was mixed with 1 μl loading buffer and added to a 2% 
(wt/vol) agarose gel, and an electrophoresis was run at 100 mV for 40 min. Gel was 
stained with ethidium bromide and the DNA bands were visualized and photographed 
under UV illumination at  BIO-RAD Universal Hood II imaging system (Bio Rad, 
Hercules, CA). MRSA strain ATCC43300 containing both nuc and mecA genes was 
used as the positive control. After the multiplex PCR pre-screening, a broth sample 
with nuc and/or mecA positive were spread on Baird Parker (BP) agar (BD 
Diagnostic Systems, Sparks, MD). In addition, if a broth sample showed positive of 
the two target genes, it was also spread on a BP agar with 2µg/ml cefoxitin. After 
being incubated at 35℃ for 48 hours, 2-4 typical S. aureus colonies from BP agar and 
all typical S. aureus colonies from BP agar + 2µg/ml cefoxtin were streaked on Blood 




creamy appearance on BPA were saved in BHI broth with 50% glycerol at -80°C for 
further study. 
 
Colony Hybridization  
In order to increase the probability of isolating MRSA, colony hybridization 
that directly targeted mecA gene was performed for broth samples positive of both 
nuc and mecA genes at PCR pre-screening. A DNA probe specific for mecA gene 
was generated by PCR. The PCR reaction contained 2 μl of DNA template, 2.5 μl of 
10×PCR buffer, 2 μl of a 1.25 mM mixture of labeled deoxynucleoside triphosphate 
(dNTP+ddNTP) (Roche, CH-4070 Basel, Switzerland), 4 μl of 25 mM MgCl2, and 
0.25 μl of 5 U of AmpliTaq Gold DNA polymerase (Applied Biosystems, 
Branchburg, NJ) and 0.5 μl (25pmol) of each oligonucleotide primer (Invitrogen, 
Carlsbad, CA). Thermocycling protocol included an initial denaturation at 95 °C for 
10 min, followed by 30 cycles of denaturation (95 °C for 30 s), annealing (60 °C for 
15 s), and extension (72 °C for 45 s), and a final extension at 72 °C for 10 min. 
Enrichment broth samples positive of nuc and mecA by PCR were diluted 500,000 to 
1,000,000 times using Buffer Peptone Water. 200 µl diluted broth was spread on a 
TSA agar (BD Diagnostic Systems, Sparks, MD) and incubated at 35℃ for 24 h. The 
TSA plates with approximately 100 to 200 colonies were chosen for hybridization 
template plates. GE positive charged Nylon membrane (GE, Minnetonka, MN) was 
cut to fit the template plate and then marked for orientation, and placed on the surface 
of a prepared template plate for about 5 min. After the colonies were copied to the 




colonies. The Nylon membrane was lysed in the denature solution (0.5 M NaOH, 1.5 
M NaCl) for 15 min with bacteria side up, and placed in neutralization buffer (1.5 M 
NaCl, 1 M Tris-HCl, PH 7.4) for 15 min, followed by using 2 X SSC ( 0.3 M NaCl, 
0.03 Sodium citrate) washing for 10 min and then dried on a dry 3 MM papers for 1 
min. GS GENE UV crosslinker (Bio Rad, Hercules, CA) was used to crosslink 
bacteria DNA to the Nylon membrane for 5min under C-L energy program. After the 
DNA was fixed, the membrane was transferred into 200 ml 6 X SSC solution 
(prewashing solution) and incubated in water bath at 50°C for 30 min with 150 rpm 
shaking. Cell debris on the surfaces of the membrane was gently removed by using 
Kimwipes soaked with warm prewashing buffer. A pre-hybridization step was 
performed in a hybridization tube (Fisher, Pittsburg, PA) with 15ml DIG-Easy-Hyb 
buffer (Roche, CH-4070 Basel, Switzerland) at 42°C for 1 h, and hybridization was 
carried out at 42°C overnight with 6 ml DIG-Easy-Hyb buffer containing 12 μl 
labeled mecA probe. After hybridization, the membrane was carefully pulled out from 
the hybridization tube, followed by washing twice in 2 X SSC solutions with 0.1% 
SDS (low stringency washing) at room temperature for 5 min. The washing step was 
repeated twice under condition of 0.1 X SSC solusion with 0.1% SDS (high 
stringency washing) at 68°C for 15 min. The presence of labeled probes was detected 
by alkaline phosphatase-conjugated antibody detection kit (Roche, CH-4070 Basel, 
Switzerland) and NBT/BCIP stock solution (Roche, CH-4070 Basel, Switzerland). 
The membrane was briefly rinsed in washing buffer for a few seconds and then 
incubated at room temperature for 30 min in 100ml blocking solution, and incubated 




15 min washing with 100 ml washing buffer. After washing, the membrane was 
equilibrated in 20 ml detection buffer for 2-5 min, and then transferred into 10 ml 
detection buffer with 800 μl NBT/BCIP stock solution for the coloration reaction in 
an appropriate container with dark environment and no shaking. After about 3-12 
hours, the membrane was washed with 50 ml of sterile double distilled water to stop 
the reaction when desired purple spots intensified were achieved. Then the membrane 
was compared with the original template plate with the marked orientation, and up to 
15 original colonies on the template plate were picked out to BPA and grown at 35°C 
for 24h. The positive isolates were then saved in BHI broth with 50% glycerol at -
80°C for further study. 
 
S. aureus and MRSA confirmation 
All collected isolates were confirmed by PCR and other biochemical tests for 
identification. The multiplex PCR target nuc and mecA genes was followed the same 
PCR experimental details as the PCR pre-screening. In addition, for each S. aureus 
isolate, the hemolysis morphology was observed on the BPA agar. A few colonies 
from BPA was streaked out and added to a 1.5ml centrifuge tube with 0.5ml 
coagulase rabbit plasma w/EDTA (Remel, Lenexa, KS) for coagulase test. After 2 
hours incubation at  35℃, the result was recorded based on the agglomeration in the 
tube. If the reaction was negative after 2 hours, the tubes were remained at 35℃ up to 
18 hours. In addition, one colony from BPA was streaked on a clean glass slide and 




bubbles indicate a positive reaction). The combined information from all the tests was 
used to evaluate if the isolates were confirmed as S. aureus or MRSA. 
 
Antimicrobial susceptibility test 
In order to characterize the antimicrobial resistant profile of S. aureus and MRSA 
isolates that recovered from retail meats, the Sensititre MIC susceptibility system 
(TREK Diagnostic Systems, Cleveland, Ohio) was used to simultaneously investigate 
the susceptibility to 22 different antimicrobials for saved S. aureus isolates. Minimum 
inhibitory concentrations (MIC) of 19 antimicrobials were determined including 
Chloramphenicol (CHL), Erythromycin (ERY), Clindamycin (CLI), Daptomycin 
(DAP), Oxacillin+2%NaCl (OXA), Gentamicin (GEN), Ampicillin (AMP), Linezolid  
(LZD), Penicillin (PEN), Rifampin (RIF), Vancomycin (VAN), 
Trimethoprim/Sulfamethoxazole (SXT), Levofloxacin (LEVO), Ciprofloxacin (CIP), 
Quinupristin/dalfopristin (SYN), Tigecycline (TGC), Nitrofurantoin (NIT), 
Tetracycline (TET) and Moxifloxacin (MXF). Four additional antimicrobials 
resistances were also tested including high level streptomycin resistance (STR 1000 
µg/ml), inducible Clindamycin resistance (DT 1 and DT 2), Cefoxitin resistance 
(FOXS) and high level gentomycin resistance (GEN 500µg/ml).  Each S. aureus 
isolate was grown on BPA agar at 35℃ for 24 hours. One typical colony from BPA 
agar were added to the demineralized water (TREK Diagnostic Systems, Cleveland, 
Ohio) and adjusted to a suitable turbidity using the Sensititre system (the valid 
turbidity present as a green light on the system). Then 10 μl suspension was diluted 




Cleveland, Ohio) to about 3x105 CFU/ml. Then an autoinoculator (TREK Diagnostic 
Systems, Cleveland, Ohio) was used to dispense 50 µl of cell suspension into each 
well on a Sensititre 96-well GP panel which has been pre-loaded with 22 different 
antimicrobials. Then the 96-well panel was sealed and incubated at 35℃ for 24 hours. 
The MIC results were recorded manually based on the growth of bacteria on each 
well. 
 
Characterization of MRSA  
 For further characterization of recovered MRSA strains, the tests for sub-
typing MRSA strains were performed including PFGE, SCCmec typing, PVL gene 
detection and other virulence factors detection. 
 
Pulsed Field Gel Electrophoresis (PFGE) 
After the confirmed MRSA strain grown on BPA at 35°C for 18-24 hours, a 
single colony was inoculated into BHI broth at 35-37°C for 20-24 hours. Then 1.8% 
SeaKem Gold agarose was prepared in TE buffer and the gel was placed in a 65°C 
waterbath. The incubated BHI broth suspension was adjust by turbidity on a 
MicroScan reader to a range of 1.1 to 1.3. Then 200 μl of the cell suspension was 
transfer to a 1.5 ml microcentrifuge tube and centrifuged at 13,000 rpm for 3-5 
minutes. The supernatant was disposed and the pellet was resuspended in 300 μl TE 
buffer. After the tube was equilibrated in 37°C waterbath for15 minutes, 4 μl 
lysostaphin was added into the cell suspension carefully but quickly, followed by 




mixture then was dispensed into a plug mold and solidified at a refrigerator for 10 
minutes. After being removed from the plug mold, the plug was placed into a tube 
containing at least 3 ml EC lysis buffer for cell lysis at 37°C for at least 4 hours,  the 
EC lysis buffer was poured out and the tube with plug was replaced with 4 ml TE 
buffer and placed on a rotator for 30 minutes washing. The washing than was 
repeated 3 more times and a 1mm X 10 mm size fragment was cut from a prepared S. 
aureus plug and placed in a 1.5 ml centrifuge tube with 150 μl of 1 X NEB 4 buffer 
(New England Biolabs, Ipswich, MA). After the tube was equilibrated at 25°C for 15 
min, 147 μl of 1X NEB 4 buffer with 3 μl SmaI restriction enzyme (New England 
Biolabs, Ipswich, MA) was replaced into the centrifuge tube and incubated at 25°C 
for at least 4 hours. The Salmonella braenderup strain H9812 was used as a 
molecular weight standard ladder by using XbaI restriction enzyme to cut at 37°C for 
at least 4 hours.  During the same time, 1.5 g SeaKem Gold Agarose (Lonza, 
Rockland, ME) was weighted out and placed in a 500 ml Erlenmeyer flask, and 150 
ml of 0.5 X TBE Buffer solution was added. Microwave was used to dissolve the 
agarose for 2-3 min. And then the 1% gel was placed in 55°C water bath until ready 
to pour. The restriction cut plug was gently picked out from the 1.5 ml centrifuge tube 
and loaded onto the bottom of comb, including H9812 standards on the first, middle 
and last places on the comb. Then, the 1% gel from 55°C water bath was poured to 
the gel mold.  After about 30 min solidification, the Bio Rad CHEF III system (Bio 
Rad, Hercules, CA)  was used to run the PFGE gel at the following condition: 200 
Volts, 14°C, initial switch time 5 seconds, final switch time 40 seconds and running 




minutes and was destained for 30 minutes in distilled water for 3 times. Photograph 
was obtained by using BIO-RAD Universal Hood II imaging system (Bio Rad, 
Hercules, CA) under UV light. 
 
PCR for SCCmec typing 
A multiplex PCR which contained 9 pairs of primers was performed for 
SCCmec typing, including 8 pairs of primers that target 8 different SCCmec types and 
1 pair of primers that target mecA gene (Table 2-1). The PCR were performed at a 25 
μl reaction solution containing 2 μl of DNA template, 2.5 μl of 10×PCR buffer, 2 μl 
of a 1.25 mM mixture of deoxynucleoside triphophate, 4 μl of 25mM MgCl2, and 
0.25 μl of 5 U of AmpliTaq Gold DNA polymerase (Applied Biosystems, 
Branchburg, NJ) and 0.5 μl of mixed oligonucleotide primers (Invitrogen, Carlsbad, 
CA). Thermocycling protocol included an initial denaturation at 94 °C for 10 min, 
followed by 10 cycles of denaturation (94 °C for 45 s), annealing (65 °C for 45 s), 
and extension (72 °C for 1.5 min), and another 25 cycles of denaturation (94 °C for 
45 s), annealing (55 °C for 45 s), and extension (72 °C for 1.5 min), ending with a 
extension at 72 °C for 10 min. 4 μl PCR products were mixed with 1 μl loading buffer 
and added to a 2% (wt/vol) agarose gel, and an electrophoresis was run at 100mV for 
40 min. Gels were then stained with ethidium bromide and the DNA bands were 
visualized and photographed under UV..  
 




A single PCR targeting the SPA gene which encode the S. aureus specific 
virulence factor proteinA were performed at a 25 μl reaction solution containing 2 μl 
of DNA template, 2.5 μl of 10×PCR buffer, 2 μl of a 1.25 mM mixture of 
deoxynucleoside triphophate, 4 μl of 25mM MgCl2, and 0.25 μl of 5 U of AmpliTaq 
Gold DNA polymerase (Applied Biosystems, Branchburg, NJ) and 1 μl (25pmol) of 
each oligonucleotide primer (Invitrogen, Carlsbad, CA). Thermocycling protocol 
included an initial denaturation at 94 °C for 10 min, followed by 30 cycles of 
denaturation (94 °C for 25 s), annealing (48 °C for 40 s), and extension (72 °C for 1 
min), ending with a extension at 72 °C for 10 min. 4 μl PCR products were mixed 
with 1 μl loading buffer and added to a 2% (wt/vol) agarose gel, and an 
electrophoresis was run at 100mV for 40 min. Gels were then stained with ethidium 
bromide and the DNA bands were visualized and photographed under UV 
illumination. MRSA strain ATCC43300 containing both nuc and mecA genes was 
used as the positive control.  
 
Multiplex PCR for detecting PVL and hlg genes 
A multiplex PCR targeting the PVL gene which encode the Panton-Valentine 
Leukocidin and hlg gene which encoded the γ-hemolysin were performed at a 25 μl 
reaction solution containing 2 μl of DNA template, 2.5 μl of 10×PCR buffer, 2 μl of a 
1.25 mM mixture of deoxynucleoside triphosphate, 4 μl of 25mM MgCl2, and 0.25 μl 
of 5 U of AmpliTaq Gold DNA polymerase (Applied Biosystems, Branchburg, NJ) 
and 0.5 μl (25pmol) of each hlg oligonucleotide primer and 0.5 (12.5pmol) of each 




included an initial denaturation at 94 °C for 10 min, followed by 30 cycles of 
denaturation (94 °C for 30 s), annealing (55 °C for 30 s), and extension (72 °C for 1 
min), ending with a extension at 72 °C for 10 min. 4 μl PCR products were mixed 
with 1 μl loading buffer and added to a 2% (wt/vol) agarose gel, and an 
electrophoresis was run at 100mV for 40 min. Gels were then stained with ethidium 
bromide and the DNA bands were visualized and photographed under UV 
illumination. MRSA strain ATCC43300 containing both nuc and mecA genes was 
used as the positive control. 
 
Statistical analysis 
Statistical analyses were performed in SPSS v13.0 (SPSS, Inc. Chicago, Illinois, 
USA). χ2 test was performed to compare three or more groups of categorical data, 
and Fisher’s exact test was performed to compare two sites of data. P value < 0.05 has 






















Table 2-2. Oligonucleotide primers used for PCR assays 
Primer Name Primer Sequence Specificity 
Product Size 
(bp) Reference 
mecA-F AAAATCGATGGTAAAGGTTGGC mecA 533 K. Murakami et al. 1991 
mecA-R AGTTCTGCAGTACCGGATTTGC    
nuc-1 GCGATTGATGGTGATACGGTT nuc 270 O. G Brakstad et al. 1992 
nuc-2 AGCCAAGCCTTGACGAACTAAAGC    
mecA2-F CTCAGGTACTGCTATCCACC mecA 448 G. Sakoulas et al. 2001 
mecA2-R CACTTGGTATATCTTCACC    
Type I-F  GCTTTAAAGAGTGTCGTTACAGG SCCmec I 613 K. Zhang et al. 2005 
Type I-R GTTCTCTCATAGTATGACGTCC    
Type II-F  CGTTGAAGATGATGAAGCG SCCmec II 398 K. Zhang et al. 2005 
Type II-R CGAAATCAATGGTTAATGGACC    
Type III-F  CCATATTGTGTACGATGCG SCCmec III 280 K. Zhang et al. 2005 
Type III-R  CCTTAGTTGTCGTAACAGATCG    
Type IVa-F  GCCTTATTCGAAGAAACCG SCCmec IVa 776 K. Zhang et al. 2005 
Type IVa-R  CTACTCTTCTGAAAAGCGTCG    
Type IVb-F  TCTGGAATTACTTCAGCTGC SCCmec IVb 493 K. Zhang et al. 2005 
Type IVb-R  AAACAATATTGCTCTCCCTC    
Type IVc-F  ACAATATTTGTATTATCGGAGAGC SCCmec Ivc 200 K. Zhang et al. 2005 
Type IVc-R  TTGGTATGAGGTATTGCTGG    
Type IVd-F5  CTCAAAATACGGACCCCAATACA SCCmec Ivd 881 K. Zhang et al. 2005 
Type IVd-R6  TGCTCCAGTAATTGCTAAAG    
Type V-F  GAACATTGTTACTTAAATGAGCG SCCmec V 325 K. Zhang et al. 2005 
Type V-R  TGAAAGTTGTACCCTTGACACC    
MecA147-F  GTGAAGATATACCAAGTGATT mecA 147 K. Zhang et al. 2005 
MecA147-R  ATGCGCTATAGATTGAAAGGAT    
luk-PV-1 ATCATTAGGTAAAATGTCTGGACATGATCCA PVL 433 Gerard Lina et al. 1999 
luk-PV-2 GCATCAASTGTATTGGATAGCAAAAGC    
hlg-1 GCCAATCCGTTATTAGAAAATGC hemolysin 937 Gerard Lina et al. 1999 
hlg-2 CCATAGACGTAGCAACGGAT    
spa-1  TCAAGCACCAAAAGAGGAAGA Protein A about 263 J. Walker et al. 1998 









Chapter 3: RESULTS 
Prevalence of S. aureus and MRSA in ground meat products 
A total of 480 ground meat samples, including 231 ground pork and 249 
ground beef, were collected from three local retail stores which represented three 
different local food supply chains in the Washington DC area from March 2009 to 
March 2010. One hundred sixty two samples were collected from store A, 160 from 
store B and 158 from store C. S. aureus were recovered from 202 (42.08%) samples, 
including 117 (50.65%) ground pork and 85 (34.14%) ground beef, and ground pork 
has a significant higher level of S. aureus contamination than ground beef (Table 3-
1). In different seasons, the prevalence of S. aureus was significantly different in both 
ground beef and ground pork samples. In collected ground pork samples, S. aureus 
was recovered from 43 (36.75%) in Spring (March 2009 to May 2009), 30 (25.64%) 
in Summer (June 2009 to August 2009), 17 (14.53%) in Fall (September 2009 to 
November 2009) and 27 (20.08%) in Winter (December 2009 to March 2010) (Figure 
3-1). For ground beef, S. aureus was recovered from 33 (38.82%) samples in Spring, 
16 (18.82%) in Summer, 15 (17.65%) in Fall and 21 (24.71%) in Winter (Figure 3-1). 
During the one year sampling, 74 (45.68%) samples of chain A had S. aureus isolates 
presented, and 56 (35%) in chain B, 72 (45.57%) in chain C. Chain B had a 
significant lower level of S. aureus contamination when comparing with chain C 
(Table 3-2). In addition, because of the variety of the lean and fat ratio in ground 
beef, the S. aureus positive rate that related with the percentage of fat in ground beef 
products was also evaluated by 10 different fat contents from 4% to 27% (Figure 3-




isolated from a ground beef from chain B, which we numbered as MRSA285 (Table 
3-1), and confirmed by PCR for mecA and nuc genes. (Figure 3-3) 
 
 
Table 3-1. Prevalence of S. aureus and MRSA in ground meats 
Meat type No. of samples No. (%) of S. aureus including MRSA* 
MRSA 
alonea 
Ground Beef 249 85 (34.14) 1 (0.4) 
Ground Pork 231 117 (50.65) 0 (0) 
Totalb 480 202 (42.08) 1 (0.21) 
a. MRSA strain was isolated from the grocery store in chain B in Sep. 24. 2009 
b. considering ground beef and ground pork as one group 
*. Fisher’s exact test indicates the prevalence of S. aureus in ground beef and ground pork is 





Table 3-2. The prevalence of S. aureus in the food supply chains 
Food Chainsa No. of samples 
Total No. (%) of 
S. aureus + 
No. (%) of S. 
aureus + in 
ground Beefb 
 
No. (%) of S. 
aureus + in 
ground Porkc 
 
Chain A 162 74 (45.68) 32 (38.55) 42 (52.5) 
Chain B 160 56 (35) 24 (28.56) 32 (41.03) 
Chain C 158 72 (45.57) 29 (34.52) 43 (56.58) 
a. Fisher’s exact test indicates the prevalence of S. aureus is significantly different between chain B and chain C. 
(P<0.05) 
b.c. The prevalence of ground beef and ground pork has no significant difference in Chain A and Chain C, but is 








































Figure 3-1. Prevalence of S. aureus associated with seasons. The seasonal changes 
were investigated based on the sampling date information. Spring season began from 
March 2009 to May 2009, Summer period was defined as June 2009 to August 2009, 
Fall season was defined as September 2009 to November 2009 and Winter was 
defined as December 2009 to March 2010. Statistical analysis was performed to 
evaluate the difference between different seasons. χ2 test indicated that season has a 
significant effect on S. aureus prevalence in both ground beef and ground pork 

















































Figure 3-2. Presence of S. aureus in ground beef with different fat contents. The 
samples were collected randomly from each retail store with 10 different fat and lean 
ratio, from 27% to 4%. The data represent the change of S. aureus contamination with 




           
 
 
Figure 3-3. Multiplex PCR results of S. aureus and MRSA isolates. The size of nuc 
and mecA are 270 and 533bp, respectively. Line 1, 100bp DNA ladder; Line 2, 
Positive control of MRSA strain; Line 3,7,9,10,11,12,14,15, S. aureus strains; Line 8, 







Antimicrobial resistance patterns of S. aureus and MRSA  
After S. aureus and MRSA isolates were confirmed by PCR and biochemical 
tests, 525 S. aureus isolates, including 3 MRSA isolates, from 202 retail meat 
samples were examined for antimicrobial susceptibility using Sensititre MIC 
susceptibility system.  In our study, antimicrobial resistant S. aureus has been found 
for 13 different antimicrobials, and the most common resistance within 525 S. aureus 
isolates are TET, PEN, ERY and CLI resistance. Especially for TET, more than half 
(54.46%) of the S. aureus from contaminated meat samples show resistance to this 
drug. In addition, there are 13 samples exhibited an inducible clindamycin resistance 
(Table 3-3).  For CHL, GEN, AMP, LEVO, CIP, SYN and TGC, although a few 
resistant isolates are identified,  the MIC results show that antimicrobial resistance is 
not yet common in recovered S. aureus. For CHL, 77.52% S. aureus isolates have the 
ability to resist to 8 µl/ml CHL and 21.33% could tolerant to 16 µl/ml CHL. 
However, only 1 S. aureus strain can resist to the breakpoint concentration as CHL 
>16 µl/ml (Figure 3-4). For GEN, although there were two S. aureus isolates can be 
classified as GEN resistant S. aureus, 99.05% isolates are susceptible to this drug. 
(Figure 3-5). Most recovered S. aureus are still susceptible to AMP, but more than 
half of these isolates have certain levels of resistance and 10 (1.9%) AMP resistant S. 
aureus was identified (Figure 3-6). Penicillin as the first introduced antimicrobial to 
cure S. aureus infections still remained effective for 41.14% S. aureus isolates 
recovered from meat samples, but there were 33 (6.48%) isolates are penicillin 
resistant and 68 (12.95%) isolates have the ability to resist to 8 µl/ml PEN (Figure 3-




recovered S. aureus were still susceptible to these three drugs (SYN susceptible 
97.33%, CLI susceptible 95.24%, CIP susceptible 99.24%). ERY has 32 (6.1%) 
resistant strains identified, but 86.67% recovered isolates can only resist to 0.5 µl/ml 
ERY (Figure 3-8). TGC has 42.1% of total S. aureus isolates can resist to 0.25 µl/ml 
concentration, and 26.1% isolates have the ability to resistant near to the 0.5 µl/ml 
break point (Figure 3-9). The MIC result for TET was very unique. Almost all 
isolates presented only two level of susceptibility, either resistance (51.62%) or 
susceptible (48.19%) (Figure 3-10). Vancomycin, as the last choice for curing MRSA 
infection, is still effective for all S. aureus strains, no resistance has been observed. 
However, 84.57% isolates show resistance to 1 µl/ml vancomycin (Figure 3-11). The 
only oxacillin resistant isolates were the MRSA strain which comes from the only 
MRSA positive sample, and the rest of S. aureus strains are still susceptible for 
oxacillin (Figure 3-12). This only 1 MRSA strain shown a multi-drug resistant pattern 
to 8 different antimicrobials (Table 3-4), including ERY, OXA, AMP, FOXS, PEN, 
LEVO, CIP and MXF. For other non-MRSA S. aureus isolates, multidrug resistant 
were also exhibited. 38 (7.24%) S. aureus isolates can resist to 2 different drugs 
simultaneously and 13 (2.48%) S. aureus isolates have the ability to resist to 3 








Table 3-3. Antimicrobial resistant profiles for S. aureus positive samples including 
MRSA 
Antimicrobials a Samples (No.)b Samples (%) 
CHL 1 0.5 
ERY 16 7.92 
CLI 10 4.95 
OXA 1 0.5 
DT 13 6.44 
GEN 2 1 
AMP 7 3.47 
FOXS 1 0.5 
PEN 23 11.39 
LEVO 1 0.5 
CIP 1 0.5 
SYN 1 0.5 
TGC 4 1.98 
TET 110 54.46 
a. CHL Chloramphenicol, ERY Erythromycin, CLI Clindamycin, OXA Oxacillin+2%NaCl, DT inducible 
Clindamycin, GEN Gentamicin, AMP Ampicillin, FOXS Cefoxitin, PEN Penicillin, LEVO Levofloxacin, CIP 
Ciprofloxacin, SYN Quinupristin/dalfopristin, TGC Tigecycline, TET Tetracycline 
b. For each sample, up to 3 confirmed S. aureus or MRSA strains have been tested. The sample was recorded 




Table 3-4. Multi-drug resistant patterns for S. aureus isolates including MRSA 
No. of drugs 0 1 2 3a 4 5 6 7 8b 
% of isolates 46.1 43.62 7.24 2.48 0 0 0 0 0.57 
No. of isolates 242 229 38 13 0 0 0 0 3 
a. multi-drug resistant S. aureus was defined as the strain has the ability to resist to 3 or more antimicrobials 
simultaneously.  
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MRSA Sub-typing and virulence genes detection  
For better understanding of the recovered MRSA285 strain, sub-typing was 
performed using PFGE and SCCmec chromosome cassette typing. In addition, several 
virulence genes were also performed to help characterize this MRSA strain. 
Compared with standard strains, PFGE results indicated all five isolates showed an 
identical profile to USA300 subtype (Figure 3-13). This is one of the most common 
Community Associated MRSA strains. For SCCmec typing, the PCR results showed 
that mecA, which indicated its ability to resist to β-lactams. However, no bands at 
expected positions for SCCmec on the gel (Figure 3-14), which indicted the lack of 
eight typical SCCmec types. The results for detecting virulence genes showed the 
presence of PVL and SPA genes (Figure 3-15). In addition, PVL gene of the 





























Figure 3-13. Pulsed-field Gel Electrophoresis (PFGE) for MRSA. The PFGE typing 
followed the CDC PulseNet protocol of molecular typing of oxacillin-resistant 
Staphylococcus aureus by PFGE. 5 single colonies were picked out from the MRSA 
positive sample. After confirmation, these 5 single colonies were inoculated in BHI 
broth and followed by PFGE test. This figure represents that PFGE patterns on the gel 
under UV light. From left to right: Line 1, 6 and 10, H9812 Ladder. Line 2, 3, 4, 7 
and 8, MRSA isolates from ground beef in this study (USA300). Line 5 and 9, MRSA 


























Figure 3-14. PCR for SCCmec typing. 5 MRSA isolates from the same MRSA 
positive sample were cultured on BPA for 24 hours at 35°C. After the genomic DNA 
have been extracted by boiling at 100°C for 15 min, a multiplex PCR with 9 sets of 
primers was performed for these 5 isolates. Each set of primer amplifies one SCCmec 
type; and1 set of primer which amplifies the mecA gene has also been included. From 
left to right: Line 1 and 10, 100bp DNA ladder. Line 2-6, 5 repeats of MRSA strain 
from this study. Line 7, MRSA strain from previous study in UMD. Line 8, 
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Figure 3-15. PCR for detecting PVL and SPA genes. 5 MRSA isolates from the same 
MRSA positive sample were cultured on BPA for 24 hours at 35°C. After the 
genomic DNA have been extracted by boiling at 100°C for 15 min, PCR was 
performed for these 5 isolates to detect PVL gene (A) and SPA gene (B). From left to 
right: (A): Line 1, 100bp DNA ladder. Line 2-6, MRSA strain from this study. (B): 
Line 10, 100bp DNA ladder. Line 2-6, MRSA strain from this study. Line 1 and 9, 





Chapter 4:  DISCUSSION 
S. aureus as a ubiquitous bacterium is the leading cause of superficial 
infection at the clinical environment for decades and also considered as the third most 
important cause of reported food-borne illnesses in the world (92). As the result of the 
widely use of antimicrobials, MRSA caused the increase of hospital-acquired 
infection (97). And in the past 20 years, the rising number of infections out of 
hospital environment caused by CA- MRSA indicated the spreading of MRSA from 
hospital to our daily life. Since a large number of animals can be colonized with S. 
aureus and the use of antimicrobial agents in veterinary medicine is very common,  
the increase of antimicrobial resistance was observed and MRSA strains were isolated 
from several common food animals, including cattle, pigs, chicken (54, 98-100). 
During slaughtering of food animals which had been colonized with MRSA, food 
products may eventually be contaminated with MRSA. In addition, inappropriate 
handling of food products or contact with MRSA carrier may also cause the food 
contaminated with MRSA (101-102). Under these circumstances, food products, 
especially fresh raw meats have the potential to transfer S. aureus or MRSA from 
animals to humans.  
In this study, 480 raw ground meat samples collected from March 2009 to 
March 2010 were examined for S. aureus.  Approximately 42% (202) of the samples 
were positive of S. aureus. The positive rate for ground beef was 34.14% and for 
ground pork was 50.65%. Compared with our previous study in 2008, which showed 
27.8% of ground beef and 11.7% of ground pork samples were positive of S. aureus, 




methods used. In this study, a selective enrichment broth was added to increase the 
number of the target bacterium before using selective media. Researchers in 
Netherland reported the prevalence of S. aureus was 33.33% in beef and 45.31% in 
pork (103).  Pesavento et al. reported 29.41% of beef, 15.15% of pork meat were 
positive in Italy (104). Another study conducted in Italy found S. aureus in 31.2% 
ground meat and 26.1% in fresh meat (92). In US, a study by Pu et al. reported S. 
aureus in 20% beef samples and 45.6% in pork samples in Louisiana (93). Many 
factors, such as sampling, isolation methods and geological locations, may contribute 
to the variety of positive percentages and also make the comparisons between 
different studies difficult. The lacking of a well established standard isolation method 
also makes the evaluation of our methodology very intricate. For the study performed 
in Louisiana which used a protocol similar to ours, the higher prevalence rate our 
study reported may attribute to the difference of sample types. Instead of taking beef 
steaks and pork chops, we collected ground beef and pork products. Based on the 
facts of raw meat products manufacturing, ground meat generally mixed by different 
parts of food animals and more than one single food animal for each lot, which 
indicated that ground meat has the higher probability to be contaminated during 
processing if food animals carried S. aureus. From the existing research data, 
although direct comparison is not suitable between these studies, all results indicated 
that S. aureus is not a rare bacterium in various food samples. Our data also showed a 
similar prevalence rate of  S. aureus in ground beef and pork from different retail 
stores under three chain managements. In addition, the data, which analyzed the 




was a significant factor that affected S. aureus contamination rate in Spring (March to 
May). More S. aureus contaminated samples were identified in Spring and Winter. 
Comparing with one clinical study, Skull et al. reported a peak incidence of S. aureus 
infection in hospital occurred between October to March (105).  Interestingly, the 
seasons with the highest recovery rate of S. aureus in meat samples matched with the 
peak season of S. aureus infections in hospitals. This may imply the possible 
relationship between S. aureus carriers and contaminated food products. Because a 
higher S. aureus infection indicated a higher S. aureus colonization in human, this 
may eventually lead to a higher contamination rate in food due to the contact of food 
and handlers. This corresponding data in our study may also indirectly prove that 
food handler is a majority contamination sources for S. aureus in food. Additionally, 
an irregular change between S. aureus recovering rate and the various percent of fat 
in ground beef seemed that the contamination rate of S. aureus had no relation to the 
fat contents in food product. 
Among the 202 S. aureus positive samples, only one ground beef was 
contaminated with MRSA. The prevalence of MRSA in this study was 0.21% (0% in 
ground pork, and 0.4% in ground beef). MRSA was detected in 3.3% beef samples 
and in 5.6% pork in Louisiana (93).  An earlier study in our lab also identified one 
MRSA from a ground pork sample of  694 meat samples (0.14%) collected. Two 
independent studies in Netherlands  reported MRSA in 3.13% pork samples, 0% beef 
samples (103) and in 10.6% beef and 10.7% pork samples (101). Again, various 
factors could contribute to the differences in these studies, directly comparing the 




presented in the tested food products, the positive rate remained low.  In our study, 
we also tried to add colony hybridization in our isolation method to increase the 
probability of isolating MRSA, the positive rate for MRSA still remained to be a very 
low level. On the other hand, the presence of MRSA in various meat products 
demonstrated that food has the potential to serve as a transmission vehicle to spread 
MRSA in our community. 
One dilemma for studying MRSA is the classification of MRSA and MSSA. 
Because of the changing concept on MRSA, there are no unified standards to evaluate 
if one S. aureus strain is MRSA or not. The questions, such as which antimicrobials 
should be used as selective agents to isolate MRSA, should antimicrobial resistance 
results be used as the standard to separate MRSA from MSSA, or if molecular based 
detection methods targeting specific genes are the better distinction method, are still 
under debate. Pereira reported that in Portugal 38% of S. aureus isolates were 
oxacillin resistant but only 0.68% of the isolates contain mecA gene, which was 
recognized as the most important gene marker to differentiate MRSA (56). Similar 
situation occurred in Italy, a study found 30% of S. aureus positive beef samples and 
10% of S. aureus positive pork samples were resistant to oxacillin, but none of S. 
aureus isolate resistant to methicillin (104). This dilemma makes the studies of 
MRSA difficult to evaluate, and the comparison of different studies from various 
researchers or locations also become very complex. In our study, MRSA identified as 
S. aureus with oxacillin resistance  containing mecA gene. 
In this study, the AST results for S. aureus isolates show that the antimicrobial 




ERY (7.92%). The research data from other studies in different countries showed 
various patterns on antimicrobial resistance. The study in Portugal reported 0.7% 
resistance in TET, 73% in PEN and 5% in ERY. In addition, 70% S. aureus were 
resistant to AMP, which only had 3.47% resistance in our study (56). The AST study 
on S. aureus in Italy found 19.04% S. aureus isolates from meat samples were 
resistant to TET, 16.66% resistant to PEN, and 42.86% to AMP (104). A study in 
Turkey also reported 53.8% PEN resistance and 7.5% ERY resistance (106). As each 
independent study used a different AST protocol, data comparison among these 
studies can be challenging.  Antimicrobial resistance patterns of S. aureus strains 
from various locations showed noticeable differences. The strains category and 
classification may also be different.  When comparing the resistance results with the 
our previous study with 68.5% to TET, 26% to PEN, 8% to ERY and 17% to AMP, 
the differences were not significant.   
In addition to MRSA, multi-drug resistance were also found in S. aureus 
isolates. Pesavento et al. reported that 9.52% of S. aureus were resistant to two 
antimicrobials and 30.95% to three or more antimicrobials (104).  However, the only 
strain resistant to oxacillin was the MRSA strain. It was resistant to eight 
antimicrobials, including FOXS which is commonly used for MRSA screening. 
Multiplex PCR identified both nuc and mecA. It belonged to USA300, A CA-MRSA. 
The MRSA strain recovered in our previous study belonged to USA100 HA-MRSA 
based on PFGE and the presence of PVL gene. The study in Louisiana also 
discovered both USA100 and USA300 MRSA from meat products (93).  The 




of HA-MRSA from healthcare facility to community. However, as the borders to 
distinguish HA-MRSA and CA-MRSA become more unclear recently, the evolution 
relationships need to be investigated.  
The absence of SCCmec in MRSA is unusual but has been observed in other 
studies.  This could be due to possible new SCCmec types as the SCCmec typing 
assay used can only identify eight most common SCCmec types.  New SCCmec types, 
such as SCCmec VI, require designing different PCR assays for detection. Therefore, 
it is not surprising that the MRSA strain did not belong to the eight most common 
SCCmec types.  Further studies are needed for better understanding the revolution of 




Chapter 5:  CONCLUSION 
Staphylococcus aureus, as the major cause of superficial infection and the 
third most important cause of reported foodborne illnesses around the world, is 
commonly present in meat products in Washington DC area. Similar findings have 
been reported by other researchers when survey studies were conducted in other states 
and countries. Although MRSA is still very rare in the meat products, the existence  
of MRSA in food samples implied the potential that MRSA can be spread in the 
community through food.  
In addition, a noticeable number of S. aureus strains from meat products have 
developed resistance to various antimicrobials, and multidrug resistant strains are not 
uncommon. With the current definition of MRSA, methicillin or oxacillin resistant S. 
aureus which is not classified by molecular based tests as MRSA also exist in food 
products. These S. aureus strains have not been well studied and could serve as 
reservoir of antimicrobial resistance genes and potentially cause infections that can 
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